Cost-effectiveness analysis of subcutaneous immunoglobulin replacement therapy in Iranian patients with primary immunodeficiencies

Lignende værker

• Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease
  af: Skoda-Smith, Suzanne, et al.
  Udgivet: (2010)
• Primary immunodeficiency disease: a cost-utility analysis comparing intravenous vs subcutaneous immunoglobulin replacement therapy in Australia
  af: Windegger, Tanja M., et al.
  Udgivet: (2020)
• Efficacy and safety of home-based subcutaneous immunoglobulin replacement therapy in paediatric patients with primary immunodeficiencies
  af: Borte, M, et al.
  Udgivet: (2011)
• The effect of subcutaneous immunoglobulin replacement therapy on serum IgG levels in patients with primary immunodeficiency
  af: Selime Özen Bölük, et al.
  Udgivet: (2023-06-01)
• Advantage of the subcutaneous immunoglobulin replacement therapy in primary immunodeficient patients with or without secondary protein loss
  af: Pınar Gür-Çetinkaya, et al.
  Udgivet: (2018-06-01)